Pirfenidone alleviates lung ischemia-reperfusion injury in a rat model.

[1]  P. V. Van Schil,et al.  Oxidative and nitrosative stress during pulmonary ischemia-reperfusion injury: from the lab to the OR. , 2017, Annals of translational medicine.

[2]  Dean P. Jones,et al.  Oxidative Stress. , 2017, Annual review of biochemistry.

[3]  A. Lichtenberg,et al.  The extracellular isoform of superoxide dismutase has a significant impact on cardiovascular ischaemia and reperfusion injury during cardiopulmonary bypass. , 2016, European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery.

[4]  R. Beyaert,et al.  TRAF2 multitasking in TNF receptor-induced signaling to NF-κB, MAP kinases and cell death. , 2016, Biochemical pharmacology.

[5]  Sonali G. Thorat,et al.  Determination and Pharmacokinetic Study of Pirfenidone in Rat Serum by High-Performance Thin-Layer Chromatography. , 2016, Journal of chromatographic science.

[6]  M. Tsuboi,et al.  A phase II trial evaluating the efficacy and safety of perioperative pirfenidone for prevention of acute exacerbation of idiopathic pulmonary fibrosis in lung cancer patients undergoing pulmonary resection: West Japan Oncology Group 6711 L (PEOPLE Study) , 2016, Respiratory Research.

[7]  A. Mehta,et al.  Complications of Lung Transplantation: A Roentgenographic Perspective. , 2016, Chest.

[8]  M. Arslantaş,et al.  Primary Graft Dysfunction after Lung Transplantation. , 2020, Turkish journal of anaesthesiology and reanimation.

[9]  M. Sonobe,et al.  Significance of single lung transplantation in the current situation of severe donor shortage in Japan , 2016, General Thoracic and Cardiovascular Surgery.

[10]  H. Date,et al.  Update on ischemia-reperfusion injury in lung transplantation , 2015, Current opinion in organ transplantation.

[11]  P. Slinger,et al.  Lung Injury After One-Lung Ventilation: A Review of the Pathophysiologic Mechanisms Affecting the Ventilated and the Collapsed Lung , 2015, Anesthesia and analgesia.

[12]  O. Rotstein,et al.  Remote Ischemic Conditioning Prevents Lung and Liver Injury After Hemorrhagic Shock/Resuscitation: Potential Role of a Humoral Plasma Factor. , 2015, Annals of surgery.

[13]  H. Tada,et al.  Pharmacokinetic evaluation of tissue distribution of pirfenidone and its metabolites for idiopathic pulmonary fibrosis therapy , 2015, Biopharmaceutics & drug disposition.

[14]  A. Camins,et al.  Pirfenidone Attenuates Microglial Reactivity and Reduces Inducible Nitric Oxide Synthase mRNA Expression After Kainic Acid-Mediated Excitotoxicity in Pubescent Rat Hippocampus , 2015, Journal of Molecular Neuroscience.

[15]  R. Chen,et al.  Determination and pharmacokinetic study of pirfenidone in rat plasma by UPLC-MS/MS. , 2015, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.

[16]  Yuanhua Yang,et al.  Inflammatory response and pneumocyte apoptosis during lung ischemia–reperfusion injury in an experimental pulmonary thromboembolism model , 2015, Journal of Thrombosis and Thrombolysis.

[17]  I. Yoshino,et al.  Experience with perioperative pirfenidone for lung cancer surgery in patients with idiopathic pulmonary fibrosis , 2015, Surgery Today.

[18]  G. Eppel,et al.  Renal oxygenation in acute renal ischemia-reperfusion injury. , 2014, American journal of physiology. Renal physiology.

[19]  Y. Miyamoto,et al.  Edaravone Suppresses Reperfusion Injury following Leg Ischemia in Rats: A Transmission Electron Microscopic Study. , 2013, The International journal of angiology : official publication of the International College of Angiology, Inc.

[20]  Steven P Jones,et al.  Historical perspective on the pathology of myocardial ischemia/reperfusion injury. , 2013, Circulation research.

[21]  H. Date,et al.  Therapeutic effect of surfactant inhalation during warm ischemia in an isolated rat lung perfusion model , 2012, Transplant international : official journal of the European Society for Organ Transplantation.

[22]  G. Visner,et al.  Inhibitory Effects of Pirfenidone on Dendritic Cells and Lung Allograft Rejection , 2012, Transplantation.

[23]  L. Feng,et al.  Effects of three anti-TNF-alpha drugs: etanercept, infliximab and pirfenidone on release of TNF-alpha in medium and TNF-alpha associated with the cell in vitro. , 2008, International immunopharmacology.

[24]  H. Zhang,et al.  NFKB and NFKBI polymorphisms in relation to susceptibility of tumour and other diseases. , 2007, Histology and histopathology.

[25]  D. Zander,et al.  Pirfenidone inhibits obliterative airway disease in mouse tracheal allografts. , 2005, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

[26]  M. Kuroki,et al.  Prevention of acute lung allograft rejection in rat by the janus kinase 3 inhibitor, tyrphostin AG490. , 2005, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

[27]  G. Visner,et al.  Pirfenidone inhibits inflammatory responses and ameliorates allograft injury in a rat lung transplant model. , 2005, The Journal of thoracic and cardiovascular surgery.

[28]  A. Kwon,et al.  Pirfenidone protects endotoxin-induced liver injury after hepatic ischemia in rats. , 2004, Transplantation proceedings.

[29]  T. Arumugam,et al.  Pirfenidone attenuates ischaemia–reperfusion injury in the rat small intestine , 2002, Clinical and experimental pharmacology & physiology.

[30]  David R. Jones,et al.  Ischemia-reperfusion injury after lung transplantation increases risk of late bronchiolitis obliterans syndrome. , 2002, The Annals of thoracic surgery.

[31]  J. Robb,et al.  Monoclonal antibody to single-stranded DNA is a specific and sensitive cellular marker of apoptosis. , 1996, Experimental cell research.